Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Verizon
VZ
|
+$91.5M |
| 2 |
VRN
Veren
VRN
|
+$44.4M |
| 3 |
Perrigo
PRGO
|
+$25.6M |
| 4 |
VER
VEREIT, Inc.
VER
|
+$7.63M |
| 5 |
Liberty Global Class C
LBTYK
|
+$6.77M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$51.2M |
| 2 |
COLE
COLE REAL ESTATE INVESTMENTS, INC COM
COLE
|
+$43.4M |
| 3 |
ExxonMobil
XOM
|
+$41.4M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$27.7M |
| 5 |
Microsoft
MSFT
|
+$27.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.36% |
| 2 | Technology | 13.06% |
| 3 | Energy | 11.79% |
| 4 | Industrials | 11.18% |
| 5 | Consumer Staples | 10.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2326
Agilysys
AGYS
$3.02B
| $302K | ﹤0.01% |
22,521
+12,300
| +120% | +$173K |
|
|
NAVB
2327
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
| $302K | ﹤0.01% |
8,150
+1,700
| +26% | +$64.5K |
|
2328
Republic Bancorp
RBCAA
$1.91B
| $301K | ﹤0.01% |
13,300
+2,700
| +25% | +$63.8K |
|
2329
Clarus
CLAR
$145M
| $300K | ﹤0.01% |
24,609
+5,022
| +26% | +$58.7K |
|
|
ALR
2330
DELISTED
AlerisLife Inc
ALR
| $298K | ﹤0.01% |
6,130
+1,160
| +23% | +$65.7K |
|
|
PTVCB
2331
DELISTED
Protective Insurance Corporation Class B Common Stock
PTVCB
| $297K | ﹤0.01% |
11,300
+1,300
| +13% | +$33.2K |
|
2332
DHI Group
DHX
$158M
| $291K | ﹤0.01% |
39,000
+5,300
| +16% | +$38.1K |
|
|
SA
2333
Seabridge Gold
SA
$3.36B
| $288K | ﹤0.01% |
40,500
+7,200
| +22% | +$61K |
|
|
SRGA
2334
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
| $288K | ﹤0.01% |
2,357
+284
| +14% | +$30.8K |
|
|
ESIO
2335
DELISTED
Electro Scientific Industries
ESIO
| $288K | ﹤0.01% |
29,200
+6,500
| +29% | +$64.9K |
|
|
BKMU
2336
DELISTED
Bank Mutual Corp
BKMU
| $288K | ﹤0.01% |
45,400
+7,000
| +18% | +$46.8K |
|
2337
FreightCar America
RAIL
$259M
| $286K | ﹤0.01% |
12,300
+3,200
| +35% | +$77.5K |
|
|
PETX
2338
DELISTED
Aratana Therapeutics, Inc.
PETX
| $286K | ﹤0.01% |
15,400
+12,100
| +367% | +$242K |
|
|
INSY
2339
DELISTED
Insys Therapeutics, Inc.
INSY
| $286K | ﹤0.01% |
13,800
+4,200
| +44% | +$83.3K |
|
2340
IDT Corp
IDT
$1.61B
| $285K | ﹤0.01% |
24,214
+4,531
| +23% | +$55.1K |
|
2341
Madrigal Pharmaceuticals
MDGL
$11.9B
| $283K | ﹤0.01% |
1,877
+334
| +22% | +$65.8K |
|
2342
PC Connection
CNXN
$2.08B
| $282K | ﹤0.01% |
13,900
+8,000
| +136% | +$173K |
|
|
ZEUS
2343
DELISTED
Olympic Steel
ZEUS
| $281K | ﹤0.01% |
9,800
+1,400
| +17% | +$39.5K |
|
|
OLP
2344
One Liberty Properties
OLP
$512M
| $279K | ﹤0.01% |
13,100
+2,800
| +27% | +$60K |
|
|
GFIG
2345
DELISTED
GFI GROUP INC
GFIG
| $279K | ﹤0.01% |
78,600
+15,900
| +25% | +$61.7K |
|
2346
NWPX Infrastructure Inc
NWPX
$1.1B
| $278K | ﹤0.01% |
7,700
+1,500
| +24% | +$53.5K |
|
|
BIRT
2347
DELISTED
Actuate Corp
BIRT
| $277K | ﹤0.01% |
46,000
+9,700
| +27% | +$63.9K |
|
|
BLUE
2348
DELISTED
bluebird bio
BLUE
| $275K | ﹤0.01% |
934
+602
| +181% | +$182K |
|
2349
MIND Technology
MIND
$45.6M
| $272K | ﹤0.01% |
1,950
+190
| +11% | +$28.7K |
|
|
CBEY
2350
DELISTED
CBEYOND INC COM STK
CBEY
| $272K | ﹤0.01% |
37,500
+3,300
| +10% | +$23.2K |
|
Similar funds
Swiss National Bank's Q1 2014 Portfolio in Review
As of Q1 2014, Swiss National Bank held 2,515 positions worth $25.5B, down 0.58% from $25.6B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Trading was light in Q1 2014: portfolio turnover was 1.2%. Swiss National Bank opened 8 new positions and exited 21, leaving the 2,515-position portfolio largely intact.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, up from 13% a quarter earlier, followed by Technology and Energy.
- Swiss National Bank's largest Q1 2014 buy was Veren: 1,374,746 shares worth $46M.
- Swiss National Bank added most to Verizon in Q1 2014, an estimated $91.5M increase.
- Swiss National Bank's biggest Q1 2014 reduction was Apple, cutting an estimated $51.2M.
- Swiss National Bank fully exited COLE REAL ESTATE INVESTMENTS, INC COM in Q1 2014, selling an estimated $43.4M.
- Swiss National Bank's ten largest holdings make up 13% of its $25.5B portfolio in Q1 2014.
- Swiss National Bank opened 8 new positions and closed 21 in Q1 2014.
- Swiss National Bank's portfolio value fell 0.58% quarter-over-quarter to $25.5B.
Based on Swiss National Bank's 13F filing for Q1 2014, filed 6 May 2014.